Alterations of epigenetics and microRNA in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q45925779

about

Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells.Long non-coding RNAs: critical players in hepatocellular carcinoma Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis.MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells New insights on the role of epigenetic alterations in hepatocellular carcinoma.Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells.Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish.The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.Demethylation effects of elemene on the GSTP1 gene in HCC cell line QGY7703 Emerging role of SETDB1 as a therapeutic target.Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells.Molecular Pathogenesis of Hepatocellular Carcinoma.New Tools for Molecular Therapy of Hepatocellular Carcinoma.

P2860

Q26782003-A35654A3-D0B0-469A-9885-CB9DEC60EA13 Q33588150-F7A710E2-1307-406F-8D1D-2997A6508E10 Q34107419-A5B9215B-CFF1-4464-A394-31E4C034AF98 Q34685418-36887169-C46C-486C-9BEE-F4C5F16DC017 Q35227134-8B274886-6B01-4812-ACB4-4F93E48EE03B Q36089730-FE2CDF6C-86CD-4410-A96E-4F1B290EE663 Q37031728-520D60E5-7506-4832-A6A9-B4540C8D5F66 Q37151483-1A40E3F8-C3C0-4605-A0F5-2AB66E5E62CB Q37492529-707BD8FD-A879-4595-AE2F-37A65D1CDD30 Q38635474-FCE4B3D4-AA2B-4433-8EFE-5A28D290184A Q38778613-00622384-1F5E-426C-BC3E-356100E6C677 Q39079803-FF53818C-A0C8-4AA0-BB63-6F4C851F5875 Q39330528-2855458F-2175-478E-A099-EA40476A7DAD Q39985681-E1491930-16E4-4D6A-B728-DC0DB6FC2660 Q41544729-BC233AF5-153C-4106-B2B3-BBB0F6BB3E6E Q41889250-625AC572-FA59-4CC8-8ACB-FE0414E05598

P2860

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q45925779

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

@en

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

@nl

type

label

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

@en

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

@nl

prefLabel

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

@en

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

@nl

P1433

Q45925779-1CD8F9EA-B0A6-44F3-BFE8-643CE21ECD17

P1476

Q45925779-C3F52F3A-F064-46D0-838E-CA1231B6D584

P2093

Q45925779-18D1E9B5-CA72-458E-A8A3-E91EC057B465

Q45925779-353B0A99-B979-49AA-A9B7-9A0053F8673D

Q45925779-89516AC1-AC7D-4FA2-9CA2-30397ADCEC50

P2860

Q45925779-00662E8C-8123-4BD2-8018-93BB8643C711

Q45925779-011ACB4D-2F9B-46A3-AFE2-901AAF426915

Q45925779-05AC2D0D-8972-4401-ADCD-139D487371D4

Q45925779-07376A07-33F4-42F1-83B3-A90419B46B42

Q45925779-0D92CEAE-222A-47EE-9866-B0C3076187DE

Q45925779-101F6FE7-68E2-41A0-934C-73323588DD7A

Q45925779-175CBAC8-33C4-4D64-AE45-C63CBF4E436B

Q45925779-24FAB332-10AE-497C-919D-AE6440EB1C4F

Q45925779-2B28746F-CC4C-4344-B354-54D4F034FE87

Q45925779-2B51C8D6-2515-45FA-997E-36D60EF6CCA4

P304

Q45925779-18E7A0F0-9774-4E39-A923-3C812B6FA128

P31

Q45925779-6C22C6B3-92C9-4403-9418-AC32EBF7B735

P356

Q45925779-37DD78FA-2284-40B3-B8A9-4B44A939A90F

P433

Q45925779-A313A60B-330C-4007-8CF2-BB1093100DAD

P478

Q45925779-1FE232B2-C649-425A-B75A-5F686E99C5EA

P577

Q45925779-006B1E22-3FDD-473D-B683-6B3D086762F2

P5875

Q45925779-EBE4529E-2D89-4817-8B62-221BEA817AB2

P698

Q45925779-9C49192E-FD66-444C-B096-D3474760FD82

P921

Q45925779-71A2D11F-8890-44E7-BE1E-08DADB21D798

P356

P1433

Hepatology Research

P1476

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

@en

P2093

Hidetsugu Saito

http://www.w3.org/2001/XMLSchema#string

Sana Hibino

http://www.w3.org/2001/XMLSchema#string

Yoshimasa Saito

http://www.w3.org/2001/XMLSchema#string

P2860

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

Translating the Histone Code

Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

miR-221 overexpression contributes to liver tumorigenesis

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications

MicroRNAs: small RNAs with a big role in gene regulation

P304

31-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEPR.12147

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236336621

http://www.w3.org/2001/XMLSchema#string

P698

23617364

http://www.w3.org/2001/XMLSchema#string

P921